Advertisement

Adenovirus-Mediated Drug-Sensitivity Gene Therapy for Hepatocellular Carcinoma

  • Fumihiko Kanai
  • Makoto Ohashi
  • Paola A. Marignani
  • Yasushi Shiratori
  • Hirofumi Hamada
  • Masao Omata
Protocol
  • 354 Downloads
Part of the Methods in Molecular Medicine™ book series (MIMM, volume 45)

Abstract

Selective gene therapy represents a potent approach in cancer treatment that utilizes a cell’s own nontoxic suicide genes. Currently, the suicide genes under investigation mediate sensitivity by encoding viral or bacterial enzymes that convert inactive prodrug into toxic antimetabolites that inhibit nucleic acid synthesis (1,2).

Keywords

Adenovirus Vector Uninfected Cell Bystander Effect Suicide Gene Cytosine Deaminase 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Moolten, F. L. (1994). Drug sensitivity (“suicide”) genes for selective cancer chemotherapy. Cancer Gene Ther. 1, 279–287.PubMedGoogle Scholar
  2. 2.
    Roth, J. A. and Cristiano, R. J. (1997). Gene therapy for cancer: what have we done and where are we going? J. Natl. Cancer Inst. 89, 21–39.CrossRefPubMedGoogle Scholar
  3. 3.
    Calabresi, P. and Chabner, B. A. (1995) Chemotherapy of neoplastic diseases. in Goodman and Gilman’s The Pharmacological Basis of Therapeutics (9th ed.) (Hardman, J. G., Limbird, L. E., Molinoff, P. B., Ruddon, R. W., and Gilman, A. G. eds. ) Pergamon New York, pp. 1225–1287.Google Scholar
  4. 4.
    Kanai, F., Kawakami, T., Hamada, H., Sadata, A., Yoshida, Y., Tanaka, T., et al. (1998) Adenovirus-mediated transduction of Escherichia coli uracil phosphoribosyl-transferase gene sensitizes cancer cells to low concentration of 5-fluorouracil. Cancer Res. 58, 1946–1951.PubMedGoogle Scholar
  5. 5.
    Miller, N. and Whelan, J. (1997). Progress in transcriptionally targeted and regulatable vectors for genetic therapy. Hum. Gene Ther. 8, 803–815.CrossRefPubMedGoogle Scholar
  6. 6.
    Niwa, H., Yamamura, K. I., and Miyazaki, J. I. (1991). Efficient selection for high expression transfectants with a novel eukaryotic vector. Gene. 108, 193–200.CrossRefPubMedGoogle Scholar
  7. 7.
    Kanegae, Y., Lee, G., Sato, Y., Tanaka, M., Nakai, M., Sakaki, T., et al. (1995) Efficient gene activation in mammalian cells by using recombinant adenovirus expressing site-specific Cre recombinase. Nucleic Acids Res. 23 (19), 3816–3821.CrossRefPubMedGoogle Scholar
  8. 8.
    Miyake, S., Makimura, M., Kanegae, Y., Harada, S., Sato, Y., Takamori, K., et al. (1996) Efficient generation of recombinant adenoviruses using adenovirus DNAterminal protein complex and a cosmid bearing full-length virus genome. Proc. Natl. Acad. Sci. USA 93 (3), 1320–1324.CrossRefPubMedGoogle Scholar
  9. 9.
    Kanai, F., Shiratori, Y., Yoshida, Y., Wakimoto, H., Hamada, H., Kanegae, Y., et al. (1996) Gene therapy for α-fetoprotein producing human hepatoma cells by adenovirus-mediated transfer of herpes simplex virus thymidine kinase gene. Hepatology. 23, 1359–1368.PubMedGoogle Scholar
  10. 10.
    Kanai, F., Lan, K.-H., Shiratori, Y., Tanaka, T., Ohashi, M., Yoshida, Y., et al. (1997). In vivo gene therapy for α-fetoprotein producing hepatocellular carcinoma by adenovirus-mediated transfer of cytosine deaminase gene. Cancer Res. 57, 461–465.PubMedGoogle Scholar
  11. 11.
    Lan, K. H., Kanai, F., Shiratori, Y., Ohashi, M., Tanaka, T., Yoshida, Y., et al. (1997). In vivo selective gene e×pression and therapy mediated by adenoviral vector for human carcinoembryonic antigen-producing gastric carcinoma. Cancer Res. 57, 4279–4284.PubMedGoogle Scholar
  12. 12.
    Kaneko, S., Hallenbeck, P., Kotani, T., Nakabayashi, H., McGarrity, G., Tamaoki, T., et al. (1995). Adenovirus-mediated gene therapy of hepatocellular carcinoma using cancer-specific gene expression. Cancer Res. 55, 5283–5287.PubMedGoogle Scholar

Copyright information

© Humana Press Inc., Totowa, NJ 2000

Authors and Affiliations

  • Fumihiko Kanai
    • 1
    • 2
  • Makoto Ohashi
    • 2
  • Paola A. Marignani
    • 3
    • 1
  • Yasushi Shiratori
    • 2
  • Hirofumi Hamada
    • 4
  • Masao Omata
    • 2
  1. 1.Department of Cell BiologyHarvard Medical SchoolBoston
  2. 2.Department of GastroenterologyUniversity of TokyoTokyoJapan
  3. 3.Division of Signal Transduction,Department of Medicine,Beth Israel Deaconess Medical Center and Department of Cell BiologyHarvard Medical SchoolBostonMA
  4. 4.Department of Molecular Biotherapy Research, Cancer Chemotherapy Center, Cancer InstituteJapanese Foundation for Cancer ResearchTokyoJapan

Personalised recommendations